Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Medical Affairs describes itself as a third strategic pillar in the biopharmaceutical and MedTech industries alongside R&D and Commercial. But is this truly the case or is Medical Affairs' strategic role still aspirational? And if it is in some ways aspirational, what does Medical Affairs need to do in order to truly achieve its position alongside R&D and Commercial? Here, three Medical Affairs leaders discuss these questions and offer their perspective for the future of the function.
Precision Value & Health partners with life science companies to establish and communicate the clinical, economic, and humanistic value of innovative therapies.
This podcast addresses what the role of Medical Affairs is in creating health equity and whether Medical Affairs is able to promote health equity in ways it couldn’t previously.
In this white paper we will discuss various insights that should inform the creation and refinement of the iMC Strategy and Plan (iMC S/P), in addition to the traditional inputs that Medical Communications teams commonly use. The objectives are to (1) explain value of an insights-driven collaborative approach to creating an iMC S/P, (2) elucidate best practices for collecting and synthesizing integrated insights that are relevant to Medical Communications, and (3) operationalizing an insights-driven approach to create and update an iMC S/P.
We partner with our clients to turn science into value by helping them understand the potential of their molecules, shaping their strategic plans and allowing their decision making to be the biggest differentiating factor in the success of their products.
It can be challenging to remember to log into each of the systems consistently enough to remain aware of information that allows you to be best prepared for engagements, identify new opportunities to engage, and discover KOL insights. The best way to make sure you are getting the maximum impact on the data and systems you have available to you is to set up automated alerts.
PwC partners with our clients to identify the scope of each company’s needs, and support Medical Affairs through the transformation journey.
Insights management is widely acknowledged across the pharmaceutical industry as being pivotal for informing and influencing strategy. Despite this, companies approach insights gathering in a fragmented and inefficient manner, with a lack of consistent frameworks. The risk is a loss of strategic advantage due to information being synthesized too slowly, and decisions being made on old or incomplete data.
Should teams be focussing on people, processes or technology when considering how to improve their insights gathering? The key to developing a robust insights gathering approach is striking the right balance between all three. Join this webinar to understand key steps that all Medical Affairs teams can take now to move towards a more holistic approach to insights gathering activities, allowing them to make better, faster decisions.
This webinar will address:
This podcast explores the necessity to consider communication as an essential element in the planning process for RWE studies.
MAPS is excited to announce the appointment of Tamas Koncz, MD, MSc, PhD, Chief Medical Officer for the Inflammation and Immunology Business at Pfizer, to the MAPS Board of Directors.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.